BioNTech Expands Mainz Research Hub for Personalized Cancer Therapies
BioNTech is investing heavily in expanding its clinical development centers in Mainz to strengthen its leadership in mRNA-based cancer treatments and reinforce Germany's position in biomedical innovation.